Showing results (391-400 of 1,822) with videos related to
Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|April 2, 2026
Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigationFlavia Lambertucci, Omar Motiño, Uxía Nogueira-Recalde, et al.Signal Transduction and Targeted Therapy|April 21, 2026
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemiaFanny Gonzales, Pauline Peyrouze, Djohana Laurent, et al.Signal Transduction and Targeted Therapy|April 27, 2026
Drugging the intrinsically disordered transactivation domain of androgen receptorJon K Obst, Carmen A Banuelos, Kunzhong Jian, et al.Signal Transduction and Targeted Therapy|April 6, 2026
p53: from understanding its structure to advances in therapeutic targetingWenhua Wang, Xia Liu, Hengqi Liu, et al.Signal Transduction and Targeted Therapy|April 20, 2026
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trialHong Wang, Qingyuan Wang, Shan Liu, et al.Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.Signal Transduction and Targeted Therapy|June 2, 2026
Single-cell identifies and validates human circulating Treg subtype/state Tregfci in non-small cell lung cancerXuanqi Liu, Yifei Liu, Wanxin Duan, et al.Signal Transduction and Targeted Therapy|June 2, 2026
Multi-omics and artificial intelligence for precision drug discovery and potential clinical applicationsYuqing Liu, Kun Zhu, Weijun Peng, et al.Signal Transduction and Targeted Therapy|June 1, 2026
Dual epitope anti-LILRB4 synthetic T-cell receptor and antigen receptor (STAR)-T-cell therapy for relapsed/refractory acute myeloid leukemiaMeng Lv, Hongli Zheng, Xuying Pei, et al.Signal Transduction and Targeted Therapy|June 1, 2026
Necroptosis triggers inflammatory interferon signatures in patient-derived metastatic breast cancer organoidsKaja Nicole Wächtershäuser, Jana V Schneider, Alec Gessner, et al.Pageof 183